Decreased serum neurotrophin 3 in chronically medicated schizophrenic males.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Neuroscience Letters

• Publication date

  2008-08-08

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.neulet.2008.04.027PMID 18572319
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• BDNF Levels and Genotype are Associated with Antipsychotic-Induced Weight Gain in Patients with Chronic Schizophrenia

  2008cited by this paper
• Oxidative stress in psychiatric disorders: evidence base and therapeutic implications.

  2008cited by this paper
• Allostatic load in bipolar disorder: implications for pathophysiology and treatment.

  2008cited by this paper
• Elevated serum thiobarbituric acid reactive substances in clinically symptomatic schizophrenic males.

  2008cited by this paper
• Serum neurotrophin-3 is increased during manic and depressive episodes in bipolar disorder.

  2007cited by this paper
• Brain-derived neurotrophic factor and risk of schizophrenia: an association study and meta-analysis.

  2007cited by this paper
• Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder.

  2007cited by this paper
• Serum BDNF levels and weight gain in schizophrenic patients on long-term treatment with antipsychotics.

  2007cited by this paper
• Bridging pharmacology and neurodevelopment in schizophrenia.

  2007cited by this paper
• Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: a study of patients treated with haloperidol or clozapine.

  2006cited by this paper
• Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes.

  2006cited by this paper
• Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.

  2006cited by this paper
• Decreased levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients.

  2006cited by this paper
• Associations between serum brain-derived neurotrophic factor levels and clinical phenotypes in schizophrenia patients.

  2006cited by this paper
• Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics.

  2005cited by this paper
• Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia

  2005cited by this paper
• Monocytes of allergics and non-allergics produce, store and release the neurotrophins NGF, BDNF and NT-3.

  2005cited by this paper
• Relationship of Brain-Derived Neurotrophic Factor and Its Receptor TrkB to Altered Inhibitory Prefrontal Circuitry in Schizophrenia

  2005cited by this paper
• State of the art of the neurotrophin hypothesis in psychiatric disorders: implications and limitations

  2004cited by this paper
• Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment.

  2004cited by this paper
• The production, storage and release of the neurotrophins nerve growth factor, brain‐derived neurotrophic factor and neurotrophin‐3 by human peripheral eosinophils in allergics and non‐allergics

  2003cited by this paper
• Differential influence of BDNF and NT3 on the expression of calcium binding proteins and neuropeptide Y in vivo

  2003cited by this paper
• Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls.

  2003cited by this paper
• Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients.

  2002cited by this paper
• Ventricular and periventricular structural volumes in first- versus multiple-episode bipolar disorder.

  2002cited by this paper
• Brain-Derived Neurotrophic Factor Produces Antidepressant Effects in Behavioral Models of Depression

  2002cited by this paper
• Pathways leading to apoptotic neurodegeneration following trauma to the developing rat brain.

  2002cited by this paper
• Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses.

  2001cited by this paper
• Endogenous Brain-Derived Neurotrophic Factor and Neurotrophin-3 Antagonistically Regulate Survival of Axotomized Corticospinal Neurons In Vivo

  2001cited by this paper
• Expression of neurotrophins BDNF and NT-3, and their receptors in rat brain after administration of antipsychotic and psychotrophic agents

  2000cited by this paper
• Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients

  2000cited by this paper
• The endogenous survival promotion of axotomized rat corticospinal neurons by brain-derived neurotrophic factor is mediated via paracrine, rather than autocrine mechanisms.

  2000cited by this paper
• Data and hypotheses on the role of nerve growth factor and other neurotrophins in psychiatric disorders.

  2000cited by this paper
• Pathophysiologic mechanisms in the pathogenesis and clinical course of schizophrenia.

  1999cited by this paper
• Permeability of the blood-brain barrier to neurotrophins.

  1998cited by this paper
• Neurotrophin-3 levels in the cerebrospinal fluid of patients with schizophrenia or medical illness.

  1997cited by this paper
• Concurrent Validity of the Opcrit Diagnostic System

  1996cited by this paper
• Physiology of the neurotrophins.

  1996cited by this paper
• TrkB and TrkC neurotrophin receptors cooperate in promoting survival of hippocampal and cerebellar granule neurons.

  1996cited by this paper
• Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF.

  1996cited by this paper
• Traduçao e adaptaçao de um instrumento de avaliaçao psicopatológica das psicoses: a Escala breve de avaliaçao psiquiátrica-versao ancorada (BPRS-A)

  1996cited by this paper
• An association study of a neurotrophic3 (NT‐3) gene polymorphism with schizophrenia

  1995cited by this paper
• Association of neurotrophin-3 gene variant with severe forms of schizophrenia.

  1995cited by this paper
• Stress and antidepressants differentially regulate neurotrophin 3 mRNA expression in the locus coeruleus.

  1995cited by this paper
• Severe sensory and sympathetic deficits in mice lacking neurotrophin-3

  1994influential reference
• Severe sensory and sympathetic deficits in mice lacking neurotrophin-3.

  1994cited by this paper
• Differential actions of neurotrophins in the locus coeruleus and basal forebrain.

  1993influential reference
• Brain-derived neurotrophic factor and neurotrophin-3 mRNAs are expressed in ventral midbrain regions containing dopaminergic neurons.

  1992cited by this paper
• Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal localizations.

  1991cited by this paper
• Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family

  1990cited by this paper
• NT-3, BDNF, and NGF in the developing rat nervous system: parallel as well as reciprocal patterns of expression.

  1990cited by this paper
• Neurotrophin-3: a neurotrophic factor related to NGF and BDNF.

  1990cited by this paper
• Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: developmental and topographical expression in the brain.

  1990cited by this paper

• The emerging role of furin in neurodegenerative and neuropsychiatric diseases

  2022cites this paper
• Prospects for Neurotrophic Factor-Based Early Intervention in Schizophrenia: Lessons Learned from the Effects of Antipsychotic Drugs on Cognition, Neurogenesis, and Neurotrophic Factors.

  2022cites this paper
• Risperidone Reduces Matrix Metalloproteinase-9 and Increases Neurotrophin-3 in Schizophrenia Spectrum of Disorder

  2021cites this paper
• Different serum protein factor levels in first‐episode drug‐naive patients with schizophrenia characterized by positive and negative symptoms

  2020cites this paper
• Biomarkers for ADHD: the Present and Future Directions

  2020cites this paper
• Matrix metalloproteinase-9 increases the risk of cognitive impairment in schizophrenia

  2020cites this paper
• Correlation of metabolic parameters, neurotrophin-3, and neurotrophin-4 serum levels in women with schizophrenia and first-onset depression

  2019cites this paper
• Effect of lurasidone vs olanzapine on neurotrophic biomarkers in unmedicated schizophrenia: A randomized controlled trial.

  2019cites this paper
• In schizophrenia serum level of neurotrophin-3 (NT-3) is increased only if depressive symptoms are present.

  2018cites this paper
• Brain, blood, cerebrospinal fluid, and serum biomarkers in schizophrenia.

  2018cites this paper
• The relationship of Chlamydophila pneumoniae with schizophrenia: The role of brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) in this relationship.

  2017cites this paper
• Serum brain-derived neurotrophic factor, glial-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 levels in children with attention-deficit/hyperactivity disorder

  2017cites this paper
• Serum levels of brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) in depressed patients with schizophrenia

  2016cites this paper
• Altered microRNA Expression in Peripheral Blood Mononuclear Cells from Young Patients with Schizophrenia

  2015cites this paper
• Refining and integrating schizophrenia pathophysiology - relevance of the allostatic load concept.

  2014cites this paper
• Neurotrophins in mesial temporal lobe epilepsy with and without psychiatric comorbidities.

  2013cites this paper
• Reduced density of hypothalamic VGF-immunoreactive neurons in schizophrenia: a potential link to impaired growth factor signaling and energy homeostasis

  2012cites this paper
• Avaliação dos níveis séricos das proteínas C3 e C4 em pacientes esquizofrênicos, bipolares controles saudáveis

  2011cites this paper
• Association of biomarkers and depressive symptoms in schizophrenia.

  2011cites this paper
• Increased annexin-V and decreased TNF-α serum levels in chronic-medicated patients with schizophrenia.

  2011cites this paper
• Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance.

  2011cites this paper
• Neurotrophins induce nitric oxide generation in human pulmonary artery endothelial cells.

  2011cites this paper
• Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance Níveis séricos de IL-6, IL-10 e TNF-α em pacientes com transtorno bipolar e esquizofrenia: diferenças no equilíbrio pró e antiinflamatório

  2011cites this paper
• Function of neurotrophic factors beyond the nervous system: inflammation and autoimmune demyelination.

  2009cites this paper